Tim Lankisch

Title: Tim Lankisch: Innovator in Liver Disease Diagnosis and Treatment

Introduction

Tim Lankisch is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of liver diseases. With a total of three patents to his name, Lankisch's work has the potential to impact many lives.

Latest Patents

Lankisch's latest patents focus on methods and compositions for the treatment of autoimmune hepatitis. The first patent provides methods that facilitate a diagnosis of inflammatory liver disease in a subject. This involves the detection of eotaxin-3 (E3) levels, either alone or in conjunction with eotaxin-1 (E1), and optionally with levels of CCL22 and IL15. These levels can assist in diagnosing liver diseases such as autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). The second patent similarly outlines methods for diagnosing inflammatory liver disease and facilitating treatment decisions for affected subjects.

Career Highlights

Throughout his career, Tim Lankisch has worked with esteemed institutions, including the Medical University of Hannover and the University of Alberta. His research has been pivotal in advancing the understanding of liver diseases and improving diagnostic methods.

Collaborations

Lankisch has collaborated with notable colleagues, including Abdolamir Landi and Michael Houghton. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Tim Lankisch is a distinguished inventor whose work in liver disease diagnosis and treatment showcases his commitment to medical innovation. His patents reflect a deep understanding of complex medical conditions and a desire to improve patient outcomes.